Table 3. Topical 1%CsA efficacy in oculus dexter and oculus sinister from first to last visit. The figure represents absolute numbers of eyes (and %) unless otherwise stated.
| Corneal opacification degree | G0 | G1 | G2 | |||
|---|---|---|---|---|---|---|
| OD (n = 42) | OS (n = 38) | OD (n = 15) | OS (n = 16) | OD (n = 25) | OS (n = 27) | |
| Grade 2 to grade 0 (“healed”) | 0 (0) | 0 (0) | 4 (27) | 4 (25) | 10 (40) | 8 (30) |
| Grade 2 to grade 1 (“Improved”) | 0 (0) | 1 (3) | 4 (27) | 5 (31) | 10 (40) | 13 (48) |
| Grade 2 to grade 2 (“stable”) | 16 (38) | 16 (42) | 7 (46) | 6 (38) | 5 (20) | 6 (22) |
| Grade 2 to grade 3 (“worsened”) | 26 (62) | 21 (55) | 0 (0) | 1 (6) | 0 (0) | 0 (0) |
G0: dogs without treatment, control group; G1: dogs receiving topical 1% CsA once daily; G2: dogs receiving topical 1% CsA twice daily.